Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 2, 2019 Off

BioGENEius Challenge Announces 2019 BioGENEius Hall of Fame Awardee

By BusinessWire

WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Institute announced the winner of the BioGENEius Hall of Fame Award, who will be recognized next…

June 2, 2019 Off

Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the ASCO 2019 Annual Meeting

By BusinessWire

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, will present updated interim results from a Phase II clinical…

June 2, 2019 Off

IMFINZI® (Durvalumab) is the Only Immunotherapy to Demonstrate Overall Survival at Three Years in Unresectable, Stage III Non-Small Cell Lung Cancer

By BusinessWire

Data presented at ASCO 2019 showed 57% of patients alive at three years vs. 43.5% on placebo WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca…

June 2, 2019 Off

SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer

By BusinessWire

DCVAC/LuCa decreased the risk of death in patients with stage IV NSCLC by 46% Median overall survival (OS) reached 15.5…

June 2, 2019 Off

LYNPARZA® (olaparib) First-Line Maintenance Therapy Nearly Doubled the Time Without Disease Progression or Death in Phase 3 POLO Trial for Patients with Germline BRCA-Mutated Metastatic Pancreatic Cancer

By BusinessWire

22% of Patients Receiving LYNPARZA Remained Progression-Free After Two Years vs. 10% on Placebo, Following Platinum-Based Chemotherapy AstraZeneca and Merck’s…

June 2, 2019 Off

SCIEX Celebrates 30th Anniversary of API III and Unveils Innovations at ASMS 2019

By BusinessWire

New technology innovations mark the company’s next milestones, and build on its pioneering history ATLANTA–(BUSINESS WIRE)–SCIEX, a global leader in…

June 2, 2019 Off

Pivotal Phase 3 ARTEMIS Trial Data Demonstrates Consistent Safety and Efficacy of AR101 in Children and Adolescents with Peanut Allergy

By BusinessWire

LISBON, Portugal–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today presented topline results…

June 2, 2019 Off

Talaris Therapeutics Presents Data Demonstrating Improved Quality of Life for Patients Treated with FCR001

By BusinessWire

BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential…

June 2, 2019 Off

Kite Announces End of Phase 1 ZUMA-3 Results for KTE-X19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

By BusinessWire

— Data Show High Rates of Response to Single Infusion of KTE-X19 — — Phase 2 Portion of ZUMA-3 is…

June 1, 2019 Off

IMV Inc. Presents New Positive Data from Phase 2 Monotherapy Arm of Its Decide1 Trial in Advanced Ovarian Cancer and Continued Duration of Clinical Benefits to Patients with Progression Free Survival

By BusinessWire

Tumor regressions demonstrate potential for DPX-Survivac immunotherapy in hard-to-treat solid tumors Data correlations of survivin specific T cell levels and…

Posts pagination

Previous 1 … 3,144 3,145 3,146 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine